Concepedia

Eunice Y. Lee

EY

Statistics

Publications

8

Citations

774

H-Index

8

Active since

2002

Affiliations

Massachusetts Institute of Technology(Current)

Center for Drug Evaluation and Research

Center for Cancer Research

United States Food and Drug Administration

Eunice Y. Lee is an author at Massachusetts Institute of Technology specializing in tumor biology, cell biology, and medicine.

Top concepts

Publications per year

2002–2018

8

Publications

8

FDA Approval Summary: Rucaparib for the Treatment of Patients with Deleterious <i>BRCA</i> Mutation–Associated Advanced Ovarian Cancer

Sanjeeve Balasubramaniam, Julia A. Beaver, Sara Horton et al. · Clinical Cancer Research · 2017 · 158 citations

FDA Approval Summary: Niraparib for the Maintenance Treatment of Patients with Recurrent Ovarian Cancer in Response to Platinum-Based Chemotherapy

Gwynn Ison, Lynn Howie, Laleh Amiri‐Kordestani et al. · Clinical Cancer Research · 2018 · 125 citations

E2F4 loss suppresses tumorigenesis in Rb mutant mice

Eunice Y. Lee, Hieu Cam, Ulrike Ziebold et al. · Cancer Cell · 2002 · 120 citations · Full text

, , +5

E2F3 Loss Has Opposing Effects on Different pRB-Deficient Tumors, Resulting in Suppression of Pituitary Tumors but Metastasis of Medullary Thyroid Carcinomas

Ulrike Ziebold, Eunice Y. Lee, Roderick T. Bronson et al. · Molecular and Cellular Biology · 2003 · 92 citations · Full text

, , +18

Full p53 transcriptional activation potential is dispensable for tumor suppression in diverse lineages

Dadi Jiang, Colleen A. Brady, Thomas M. Johnson et al. · Proceedings of the National Academy of Sciences · 2011 · 88 citations · Full text

1–5 of 8